Loading...
Please wait, while we are loading the content...
Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial.
| Content Provider | Europe PMC |
|---|---|
| Author | Ketteler, Markus Wiecek, Andrzej Rosenkranz, Alexander R. Pasch, Andreas Rekowski, Jan Hellmann, Burkhard Karus, Michael Ammer, Richard |
| Copyright Year | 2021 |
| Journal | Kidney International Reports |
| Volume Number | 6 |
| PubMed Central reference number | PMC7938065 |
| Issue Number | 3 |
| PubMed reference number | 33732974 |
| e-ISSN | 24680249 |
| DOI | 10.1016/j.ekir.2020.12.012 |
| Language | English |
| Publisher | Elsevier |
| Publisher Date | 2020-12-19 |
| Access Restriction | Open |
| Rights License | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). © 2021 Published by Elsevier, Inc., on behalf of the International Society of Nephrology. |
| Subject Keyword | hemodialysis hyperphosphatemia mineral and bone disease nicotinamide phosphate binder combination therapy randomized controlled trial |
| Content Type | Text |
| Resource Type | Article |
| Subject | Nephrology |